Sunshine Biopharma Inc. Operating Lease, Liability, Current
Sunshine Biopharma Inc. (SBFM) had Operating Lease, Liability, Current of $202.52 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Current $202.52K.
- 2026-03-31: Operating Lease, Liability, Current $209.23K.
- 2025-12-31: Operating Lease, Liability, Current $215.64K.
- 2025-09-30: Operating Lease, Liability, Current $218.05K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $202.52K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $209.23K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $215.64K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $218.05K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $222.50K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $213.98K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $207.76K 10-K · filed 2026-04-03 |
| 2024-09-30 | $116.25K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $114.45K 10-Q/A · filed 2024-08-20 |
| 2024-03-31 | $115.40K 10-Q · filed 2024-05-20 |
| 2023-12-31 | $118.67K 10-K · filed 2025-04-01 |
| 2023-09-30 | $117.84K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $122.15K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $121.30K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $123.03K 10-K · filed 2024-03-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-04-04 |
| 2019-03-31 | $46.46K 10-Q · filed 2019-05-20 |
| 2018-12-31 | $0.00 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |